Robb Bird, NMD FAARM Medical Director, Transformyou
Kim, MD President, Pennsylvania Pain Society
Nate News (in Korean)
The combination of afamelanotide implant plus NB-UVB achieved 48.6% repigmentation at day 168, compared to 33.3% with NB-UVB monotherapy a statistically significant and clinically meaningful difference (Lim et al., 2015)
*Results will vary from person to person depending on the individuals existing health condition, physical lifestyle, and diet
Comfrey: Some say that this herb works to relieve cough, stomach problems, and chest pain, and its even alleged to treat cancer